Found: 31
Select item for more details and to access through your institution.
Brief report of the first cured 2019-nCoV pneumonia patient in West China Hospital.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2020, v. 39, n. 8, p. 1593, doi. 10.1007/s10096-020-03866-z
- By:
- Publication type:
- Article
Molecular Mechanisms and Potential New Therapeutic Drugs for Liver Fibrosis.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.787748
- By:
- Publication type:
- Article
Inhibition of hepatitis B Virus replication by hepatocyte nuclear factor 4-alpha specific short hairpin RNA.
- Published in:
- Liver International, 2012, v. 32, n. 5, p. 742, doi. 10.1111/j.1478-3231.2011.02748.x
- By:
- Publication type:
- Article
Distribution and factors associated with serum HBV pregenomic RNA levels in Chinese chronic hepatitis B patients.
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 6, p. 3688, doi. 10.1002/jmv.26529
- By:
- Publication type:
- Article
Tenofovir monotherapy versus tenofovir plus entecavir combination therapy in HBeAg‐positive chronic hepatitis patients with partial virological response to entecavir.
- Published in:
- Journal of Medical Virology, 2020, v. 92, n. 3, p. 302, doi. 10.1002/jmv.25608
- By:
- Publication type:
- Article
Editorial: in the era of effective antiviral therapy, long‐term dynamic endoscopic monitoring does not seem to be necessary for all CHB patients with compensated cirrhosis.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Editorial: baseline hepatitis B virus haplotype number may help predict a functional cure in patients with chronic hepatitis B treated with nucleotide analogues.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Letter: serum HBV RNA and HBcrAg may help to evaluate safely stopping nucleot(s)ide analogues in patients with HBeAg‐negative chronic hepatitis B and without cirrhosis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 7, p. 1219, doi. 10.1111/apt.17154
- By:
- Publication type:
- Article
Editorial: switching to tenofovir alafenamide monotherapy is effective and safe for other nucleos(t)ide analogues‐treated patients with chronic hepatitis B.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Impact of mild to moderate elevations of alanine aminotransferase on liver stiffness measurement in chronic hepatitis B patients during antiviral therapy.
- Published in:
- Hepatology Research, 2013, v. 43, n. 2, p. 185, doi. 10.1111/j.1872-034X.2012.01068.x
- By:
- Publication type:
- Article
Plasma Apolipoprotein A-V Predicts Long-term Survival in Chronic Hepatitis B Patients with Acute-on-Chronic Liver Failure.
- Published in:
- Scientific Reports, 2017, p. 45576, doi. 10.1038/srep45576
- By:
- Publication type:
- Article
Biological characteristics comparison of HBV rtA181T mutants with truncated or substituted HBsAg expression in vitro and in vivo model systems.
- Published in:
- Scientific Reports, 2016, p. 39260, doi. 10.1038/srep39260
- By:
- Publication type:
- Article
Serum Pregenomic RNA Combined With Hepatitis B Core-Related Antigen Helps Predict the Risk of Virological Relapse After Discontinuation of Nucleos(t)ide Analogs in Patients With Chronic Hepatitis B.
- Published in:
- Frontiers in Microbiology, 2022, v. 13, p. 1, doi. 10.3389/fmicb.2022.901233
- By:
- Publication type:
- Article
Cell heterogeneity, rather than the cell storage solution, affects the behavior of mesenchymal stem cells in vitro and in vivo.
- Published in:
- Stem Cell Research & Therapy, 2021, v. 12, n. 1, p. 1, doi. 10.1186/s13287-021-02450-2
- By:
- Publication type:
- Article
Quantitative Measurement of Serum HBcrAg Can Be Used to Assess the Feasibility of Safe Discontinuation of Antiviral Therapy for Chronic Hepatitis B.
- Published in:
- Viruses (1999-4915), 2024, v. 16, n. 4, p. 529, doi. 10.3390/v16040529
- By:
- Publication type:
- Article
Prospective evaluation of FibroScan for the diagnosis of hepatic fibrosis compared with liver biopsy/AST platelet ratio index and FIB-4 in patients with chronic HBV infection.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Histological changes in chinese chronic hepatitis B patients with ALT lower than two times upper limits of normal.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Satisfactory virological response and fibrosis improvement of sofosbuvir-based regimens for Chinese patients with hepatitis C virus genotype 3 infection: results of a real-world cohort study.
- Published in:
- Virology Journal, 2018, v. 15, n. 1, p. N.PAG, doi. 10.1186/s12985-018-1066-8
- By:
- Publication type:
- Article
The truncated mutant HBsAg expression increases the tumorigenesis of hepatitis B virus by regulating TGF-β/Smad signaling pathway.
- Published in:
- Virology Journal, 2018, v. 15, p. 1, doi. 10.1186/s12985-018-0972-0
- By:
- Publication type:
- Article
Clinical treatment of cryptococcal meningitis: an evidence-based review on the emerging clinical data.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 6, p. 2960, doi. 10.1007/s00415-024-12193-8
- By:
- Publication type:
- Article
Effect of silibinin capsules combined with lifestyle modification on hepatic steatosis in patients with chronic hepatitis B.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-020-80709-z
- By:
- Publication type:
- Article
Progress in mesenchymal stem cell–based therapy for acute liver failure.
- Published in:
- Stem Cell Research & Therapy, 2018, v. 9, n. 1, p. N.PAG, doi. 10.1186/s13287-018-0972-4
- By:
- Publication type:
- Article
Rely to: 'Optimal drug administration manner would rescue partial virological response in chronic hepatitis B patients with entecavir or tenofovir treatment: Methodological issues'.
- Published in:
- Journal of Viral Hepatitis, 2021, v. 28, n. 1, p. 221, doi. 10.1111/jvh.13390
- By:
- Publication type:
- Article
Optimal drug administration manner would rescue partial virological response in chronic hepatitis B patients with entecavir or tenofovir treatment.
- Published in:
- Journal of Viral Hepatitis, 2020, v. 27, n. 7, p. 731, doi. 10.1111/jvh.13275
- By:
- Publication type:
- Article
Serum HBcrAg is better than HBV RNA and HBsAg in reflecting intrahepatic covalently closed circular DNA.
- Published in:
- Journal of Viral Hepatitis, 2019, v. 26, n. 5, p. 586, doi. 10.1111/jvh.13061
- By:
- Publication type:
- Article
Safety and efficacy of sofosbuvir‐based direct‐acting antiviral regimens for hepatitis C virus genotype 6 in Southwest China: Real‐world experience of a retrospective study.
- Published in:
- Journal of Viral Hepatitis, 2019, v. 26, n. 3, p. 316, doi. 10.1111/jvh.13033
- By:
- Publication type:
- Article
Acute-on-Chronic Liver Failure: From Basic Research to Clinical Applications.
- Published in:
- Canadian Journal of Gastroenterology & Hepatology, 2018, p. 1, doi. 10.1155/2018/5029789
- By:
- Publication type:
- Article
Efficacy and safety of telbivudine plus adefovir dipivoxil combination therapy and entecavir monotherapy for HBe Ag-positive chronic hepatitis B patients with resistance to adefovir dipivoxil.
- Published in:
- Journal of Viral Hepatitis, 2013, v. 20, p. 40, doi. 10.1111/jvh.12062
- By:
- Publication type:
- Article
The high level of IL-1β in the serum of ACLF patients induces increased IL-8 expression in hUC-MSCs and reduces the efficacy of hUC-MSCs in liver failure.
- Published in:
- Stem Cell Research & Therapy, 2023, v. 14, n. 1, p. 1, doi. 10.1186/s13287-023-03455-9
- By:
- Publication type:
- Article
Propylthiouracil-induced liver failure and artificial liver support systems: a case report and review of the literature.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Apolipoprotein A5 alleviates LPS/D-GalN-induced fulminant liver failure in mice by inhibiting TLR4-mediated NF-κB pathway.
- Published in:
- 2019
- By:
- Publication type:
- journal article